Encavis AG
OTC:ENCVF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Encavis AG
OTC:ENCVF
|
DE |
|
G
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
F:GU5
|
CN |
|
V
|
Victoria Gold Corp
OTC:VITFF
|
CA |
|
C
|
China Everbright Ltd
OTC:CEVIY
|
HK |
|
N
|
Nitto Boseki Co Ltd
SWB:NB5
|
JP |
|
Port of Tauranga Ltd
F:PKF1
|
NZ |
|
V
|
Victoria PLC
OTC:VCCTF
|
UK |
|
G
|
Granada Gold Mine Inc
SWB:B6DA
|
CA |
|
Carasent AB (publ)
F:E0C
|
SE |
|
Trustpilot Group PLC
OTC:TRTPF
|
UK |
|
B
|
Borussia Dortmund GmbH & Co KGaA
XHAN:BVB
|
DE |
|
S
|
Shui On Land Ltd
XMUN:OL5
|
CN |
|
B
|
Beijing Enterprises Holdings Ltd
DUS:BJEB
|
HK |
|
E
|
European Metals Holdings Ltd
F:E86
|
AU |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ENCVF's stock price target?
Not Available
ENCVF does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Encavis AG?
Projected CAGR
6%
Over the last 7 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 4 years is 6%.
What is the Operating Income forecast for Encavis AG?
Projected CAGR
8%
Over the last 7 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 3 years is 8%.